Market Growth Is Driven by Technological Innovations and An Increasing Incidence of Chronic Diseases.Pune, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Global Positron Emission Tomography Market Size & Growth ...
20h
News Medical on MSNNeurofilament light as a translational biomarker from preclinical drug discovery to clinical applicationNeurofilament light (NFL) is a powerful and sensitive biomarker for tracking neuronal health and disease progression.
The global positron emission tomography (PET) scanners market is set to experience significant growth, with an estimated valuation of USD 1.3 billion in 2023 and a projected increase to USD 2.1 ...
1d
News Medical on MSNBlood test for Alzheimer’s could replace costly and invasive spinal tapsResearchers indicate that the Lumipulse p-tau217 assay may reduce over 50% of lumbar punctures performed for diagnosing ...
Niagara Falls, NY, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company specializing in PET ...
RadNet (NASDAQ:RDNT – Get Free Report) is projected to release its earnings data before the market opens on Friday, February ...
Radiopharm Theranostic (RADX)s announced the publication of a novel imaging approach demonstrating proof-of-concept for the use of RAD 101 for ...
3d
ExtremeTech on MSNNew Test Spots Alzheimer's Biomarkers a Decade Before Symptoms BeginResearchers have developed a test that spots early signs of Alzheimer's disease. Rather than looking for amyloid-beta plaques ...
Positron Co. (OTCMKTS:POSC – Get Free Report) shares fell 6.2% during mid-day trading on Friday . The company traded as low as $1.78 and last traded at $1.81. 34,998 shares traded hands during trading ...
Researchers from Astrazeneca plc and Karolinska Institutet have described the positron emission tomography (PET) evaluation of [11C]AZD-2423, a chemokine receptor type 2 (CCR2) radioligand in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results